Researchers Project Huge Increase in AI Imaging Products

Oct. 16, 2023
Study published in Journal of the American College of Radiology projects there will be 147 new AI products in 2028, based on the $13 billion in funding in 2022

A study published in the Journal of the American College of Radiology projects that new U.S. Food and Drug Administration (FDA)-approved artificial intelligence (AI) medical imaging products will increase five-fold by 2035.

The research from the Harvey L. Neiman Health Policy Institute (HPI) and American College of Radiology  Data Science Institute (DSI) projected the number of new FDA-approved products using the historical relationship between the number of new products and past AI venture capital funding.

Using DSI and venture capital funding data from Rock Health’s Digital Funding Reports, the study found that annual AI funding grew from $2 billion in 2013 to $13 billion in 2022. It currently takes about six years from funding to FDA approval, and the study projects there will be 147 new AI products in 2028, based on the $13 billion in funding in 2022.

"As radiologists' workload continues to increase, AI will be a crucial tool to manage this growth over the next few decades," said Keith Dreyer, D.O., Ph.D., ACR DSI Chief Science Officer and Chief Data Science Officer at Massachusetts General Hospital and Brigham and Women’s Hospital, in a statement.

Assuming that future funding follows the same linear trend it has previously, the study projects funding will be $30.8 billion in 2029. FDA-approved products from that funding would appear in 2035.

“Given the relationship between funding and new AI products, we project there will be 350 new AI products in 2035 corresponding to the 2029 funding level given the lag between funding and approved products. This is a five-fold increase from 69 in 2022,” said Eric Christensen, Ph.D., research director at the Neiman Health Policy Institute, in a statement.

"Artificial intelligence has grown rapidly and is already changing the way healthcare professionals work," said Christopher Treml, DSI director of operations, in a statement. "Based on this research, we expect that growth to continue accelerating over the next decade and change the field in new and exciting ways as AI products are developed and integrated into practice."

Sponsored Recommendations

Telehealth: Moving Forward Into the Future

Register now to explore two insightful sessions that delve into the transformative potential of telehealth and virtual care management solutions.

How Gen AI is driving efficiency in the ED

Discover how Gen AI is revolutionizing efficiency in the Emergency Department (ED), enhancing patient care, and alleviating staffing challenges. Join Microsoft and Valley View...

7 Steps to Sharpen Your Healthcare Revenue Cycle

If you manage a healthcare revenue cycle, you know the road to quick, complete payments is rocky. Using decades of industry expertise and real-world data, we’ll help you develop...

Patient Care Resolved: How Best-in-Class Providers Eliminate Obstacles to Reduce Cost

Healthcare organizations face numerous challenges impacting care delivery and patient experiences. By eliminating obstacles to patient care delivery they can reduce operating ...